Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2022 - 03 - 09 save search
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -3.61%
H: 3.68%
C: 2.94%
conference therapeutics
Turning Point Therapeutics to Participate in Upcoming Investor Conferences
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -2.91%
H: 3.37%
C: 3.15%
conference therapeutics
Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-5001 for the Treatment of Acute Myeloid Leukemia
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
NTLA | $21.16 -1.72% -1.75% 860K
|
Health Technology
|
| O: -2.09%
H: 2.75%
C: 2.01%
ntla-5001 treatment fda myeloid leukemia drug leukemia 500 therapeutics drug designation intel orphan drug designation acute myeloid leukemia
Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: -1.22%
H: 4.02%
C: -6.19%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.02%
H: 1.86%
C: 1.21%
ASMB | $13.48 1.58% 1.56% 5.6K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.55%
air therapeutics iot
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
CCCC | $6.47 -6.23% -6.65% 1M
|
Health Technology
|
| O: 5.67%
H: 11.76%
C: 9.1%
cft8634 treatment fda drug therapeutics drug designation orphan drug designation soft tissue
Trevi Therapeutics to Report Q4 and Year End 2021 Financial Results and Provide a Corporate Update on March 17, 2022
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
TRVI | $2.68 -5.97% -6.34% 120K
|
Health Technology
|
| O: 5.03%
H: 14.97%
C: 2.99%
financial results therapeutics report results
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
KROS | $56.135 1.71% 1.68% 260K
|
Health Technology
|
| O: 2.38%
H: 7.8%
C: 5.25%
financial results therapeutics report results
Viracta Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
Published: 2022-03-09 (Crawled : 22:00) - prnewswire.com
VIRX | $0.8367 -1.31% -1.33% 55K
|
Manufacturing
|
| O: 0.0%
H: 6.61%
C: 4.28%
health thc conference therapeutics
Denali Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of DNL593 (PTV:PGRN) for Frontotemporal Dementia-Granulin (FTD-GRN)
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: 3.61%
H: 4.91%
C: 4.38%
dnl593 dementia trial therapeutics ftd-grn phase 1 phase 2
Prelude Therapeutics Provides Clinical Update and Announces Presentation of New Preclinical Data at the Upcoming 2022 AACR Annual Meeting
Published: 2022-03-09 (Crawled : 13:30) - globenewswire.com
PRLD | $3.91 1.03% 1.02% 29K
|
Health Technology
|
| O: 4.33%
H: 8.53%
C: 4.86%
therapeutics presentation preclinical pre-clinical
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Published: 2022-03-09 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: 0.0%
therapeutics
Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-09 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
LYRA | $5.23 0.38% 0.38% 120K
|
Health Technology
|
| O: -8.93%
H: 1.79%
C: -2.63%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 2.65%
H: 1.72%
C: -1.88%
financial results therapeutics report results
Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview
Published: 2022-03-09 (Crawled : 13:00) - globenewswire.com
TARA | $2.81 -6.33% -6.76% 420K
|
Health Technology
|
| O: 0.59%
H: 5.54%
C: 1.77%
financial results therapeutics results
Akari Therapeutics Announces New Data Supporting Use of Drug Candidate Votucalis Targeting Difficult to Treat Pain and Itch
Published: 2022-03-09 (Crawled : 13:00) - globenewswire.com
AKTX | $1.25 3.31% 3.2% 7.5K
|
Health Technology
|
| O: 0.0%
H: 7.89%
C: 5.26%
drug therapeutics
Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC™ Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022
Published: 2022-03-09 (Crawled : 12:00) - globenewswire.com
DSGN | $3.655 -0.14% -0.14% 190K
|
Professional, Scientific, and T...
|
| O: 2.53%
H: 12.75%
C: 8.46%
treatment therapeutics preclinical therapy pre-clinical designation
Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
Published: 2022-03-09 (Crawled : 12:00) - biospace.com/
CMMB | $0.67 0.02% 3.4K
|
Manufacturing
|
| O: 25.45%
H: 0.0%
C: -8.45%
financial results therapeutics results
Repare Therapeutics to Present Comprehensive Phase 1 Monotherapy Data From the Phase 1/2 TRESR RP-3500 Clinical Trial and SNiPDx Panel at the 2022 AACR Annual Meeting
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
RPTX 4 | $3.3 -1.79% -1.82% 73K
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: 0.0%
rp-3500 500 trial therapeutics phase 1 therapy phase 2 phase 3
Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
CNTX | $1.38 -2.13% -2.17% 37K
|
Health Technology
|
| O: 3.21%
H: 7.21%
C: 6.21%
therapeutics america ces research cancer
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.